Related Articles
Phase I study of liposomal daunorubicin in relapsed and refractory acute myeloid leukemia
INDUCTION OF RESISTANCE TO DAUNORUBICIN IN DRUG-SENSITIVE LEUKEMIA P388 CELLS - A ROLE OF PKC-BETA-I ISOZYME
Preclinical evaluation of 99mTc direct labeling ZHER2:V2 for HER2 positive tumors imaging
Novel SAHA‑bendamustine hybrid NL‑101 in combination with daunorubicin synergistically suppresses acute myeloid leukemia
Adenovirus‑mediated delivery of the human IFN‑γ gene potentiates the cytotoxicity of daunorubicin against leukemic cells through downregulation of the α4β1 integrin/ILK/apoptosis pathway